Senior Manager, External Data Acquisition, Clinical Data Management

Senior Manager In External Data Acquisition

At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

As a Senior Manager in External Data Acquisition, you will play a pivotal role within our Clinical Data Management team. Your primary responsibility will be to oversee the acquisition and integration of third-party data (e.g., laboratories, eCOA providers, technology providers, etc.) who perform testing or data collection services on behalf of Genmab, ensuring its alignment with clinical trials' objectives and regulatory standards.

Responsibilities include :

• Lead and provide strategic insights into protocol development, specifically focusing on external data collection and integration.
• Standardize data type specifications to align with Electronic Data Capture (EDC) requirements and clinical trial objectives.
• Ensure that data transfer processes comply with CDASH and SDTM standards, facilitating efficient data analysis and reporting.
• Develop detailed data transfer specifications for acquiring external data from third-party vendors.
• Coordinate with vendors to guarantee that data collection is compatible with clinical databases and meets SDTM requirements.
• Oversee Data Management Contract Research Organizations (DM CROs) for seamless external data transfers.
• Review and assess vendor contracts, setup specifications, and test data transfers.
• Proactively identify and resolve issues related to external data transfers throughout the trial lifecycle.
• Collaborate with internal teams (Biomarker Operations, Data Management, Data Analytics, Medical, Statistics, etc.) and external partners to ensure adherence to Genmab's requirements and timelines.

Requirements :

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location.

When you join Genmab, you're joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for :

You are genuinely passionate about our purpose. You bring precision and excellence to all that you do. You believe in our rooted-in-science approach to problem-solving. You are a generous collaborator who can work in teams with a broad spectrum of backgrounds. You take pride in enabling the best work of others on the team. You can grapple with the unknown and be innovative. You have experience working in a fast-growing, dynamic company (or a strong desire to). You work hard and are not afraid to have a little fun while you do so!

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you're in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.